Karyopharm Therapeutics Selects MediSpend's Transparency Solution
PORTSMOUTH, N.H., Oct. 20, 2020 /PRNewswire/ --MediSpend announced that Karyopharm Therapeutics(NASDAQ:KPTI) selected MediSpend Transparency Solution to comply with state and federal transparency reporting regulations.
- PORTSMOUTH, N.H., Oct. 20, 2020 /PRNewswire/ --MediSpend announced that Karyopharm Therapeutics(NASDAQ:KPTI) selected MediSpend Transparency Solution to comply with state and federal transparency reporting regulations.
- MediSpend Transparency Solution is a SaaS-based solution that collects, remediates, validates, analyzes and reports transfers of value to comply with state, federal and global transparency laws and codes.
- Karyopharm Therapeuticswas implemented and went live with MediSpend's Transparency Solution in October 2020.
- WithMediSpend's best-in-class Transparency Solution, Karyopharm Therapeutics will be able to efficiently and effectively manage continually evolving transparency reporting requirements.